Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation.
Ryan D CastleMichelle A WilliamsWilliam C BushellJ Adam RindfleischChristine Tara PetersonJames MarzolfKimberly BrouwerPaul J MillsPublished in: Journal of inflammation research (2021)
Nonstandard adjunctive care appeared to have comparable or superior effects in comparison to Remdesivir and Tocilizumab on the inflammatory markers most impacted by COVID-19. Alongside standards of care, melatonin, vitamin D3, and meditation should be considered for treatment of SARS-COV-2 infection and COVID-19 disease.
Keyphrases
- coronavirus disease
- sars cov
- rheumatoid arthritis
- healthcare
- respiratory syndrome coronavirus
- palliative care
- juvenile idiopathic arthritis
- quality improvement
- rheumatoid arthritis patients
- pain management
- affordable care act
- systemic lupus erythematosus
- disease activity
- health insurance
- combination therapy
- drug induced